It'll hardly be a freefall, just look at the sell side - very thin!
sp may drop back a little further but it's hardly a reflection of the company's true value.
Some investors just don't understand biotechnology and drug development - they get bored / scared / impatient, or a combination of all three and exit at the wrong time.
Luckily they're hardly major shareholders. The major shareholders in this company know how to treat this investment - leave it alone and top up while the stock is temporarily sold down.
It'll hardly be a freefall, just look at the sell side - very...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |